447 related articles for article (PubMed ID: 27510348)
1. Endocrine Society of Australia position statement on male hypogonadism (part 1): assessment and indications for testosterone therapy.
Yeap BB; Grossmann M; McLachlan RI; Handelsman DJ; Wittert GA; Conway AJ; Stuckey BG; Lording DW; Allan CA; Zajac JD; Burger HG
Med J Aust; 2016 Aug; 205(4):173-8. PubMed ID: 27510348
[TBL] [Abstract][Full Text] [Related]
2. Endocrine Society of Australia position statement on male hypogonadism (part 2): treatment and therapeutic considerations.
Yeap BB; Grossmann M; McLachlan RI; Handelsman DJ; Wittert GA; Conway AJ; Stuckey BG; Lording DW; Allan CA; Zajac JD; Burger HG
Med J Aust; 2016 Sep; 205(5):228-31. PubMed ID: 27581270
[TBL] [Abstract][Full Text] [Related]
3. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.
Bhasin S; Brito JP; Cunningham GR; Hayes FJ; Hodis HN; Matsumoto AM; Snyder PJ; Swerdloff RS; Wu FC; Yialamas MA
J Clin Endocrinol Metab; 2018 May; 103(5):1715-1744. PubMed ID: 29562364
[TBL] [Abstract][Full Text] [Related]
4. Clinical practice update on testosterone therapy for male hypogonadism: Contrasting perspectives to optimize care.
Yeap BB; Wu FCW
Clin Endocrinol (Oxf); 2019 Jan; 90(1):56-65. PubMed ID: 30358898
[TBL] [Abstract][Full Text] [Related]
5. Feedback inhibition of gonadotropins by testosterone in men with hypogonadotropic hypogonadism: comparison to the intact pituitary-testicular axis in primary hypogonadism.
Shimon I; Lubina A; Gorfine M; Ilany J
J Androl; 2006; 27(3):358-64. PubMed ID: 16474013
[TBL] [Abstract][Full Text] [Related]
6. American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients--2002 update.
Petak SM; Nankin HR; Spark RF; Swerdloff RS; Rodriguez-Rigau LJ;
Endocr Pract; 2002; 8(6):440-56. PubMed ID: 15260010
[TBL] [Abstract][Full Text] [Related]
7. Androgen therapy in the aging male.
Lunenfeld B
World J Urol; 2003 Nov; 21(5):292-305. PubMed ID: 14576959
[TBL] [Abstract][Full Text] [Related]
8. A study of the endocrine manifestations of hepatic cirrhosis.
Baker HW; Burger HG; de Kretser DM; Dulmanis A; Hudson B; O'Connor S; Paulsen CA; Purcell N; Rennie GC; Seah CS; Taft HP; Wang C
Q J Med; 1976 Jan; 45(177):145-78. PubMed ID: 769039
[TBL] [Abstract][Full Text] [Related]
9. Testosterone replacement therapy: For whom, when and how?
Tsametis CP; Isidori AM
Metabolism; 2018 Sep; 86():69-78. PubMed ID: 29530796
[TBL] [Abstract][Full Text] [Related]
10. [Testosterone replacement treatment in older people with and without co-morbidities].
Zitzmann M
Internist (Berl); 2020 Jun; 61(6):549-557. PubMed ID: 32377774
[TBL] [Abstract][Full Text] [Related]
11. [Diagnosis and treatment of hypogonadism in adult males].
Köhn FM
Hautarzt; 2004 Sep; 55(9):877-895; quiz 896-7. PubMed ID: 15484339
[TBL] [Abstract][Full Text] [Related]
12. Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men.
Lunenfeld B; Mskhalaya G; Zitzmann M; Arver S; Kalinchenko S; Tishova Y; Morgentaler A
Aging Male; 2015 Mar; 18(1):5-15. PubMed ID: 25657080
[TBL] [Abstract][Full Text] [Related]
13. Approach to the male patient with congenital hypogonadotropic hypogonadism.
Young J
J Clin Endocrinol Metab; 2012 Mar; 97(3):707-18. PubMed ID: 22392951
[TBL] [Abstract][Full Text] [Related]
14. Late-onset hypogonadism: metabolic impact.
Grossmann M; Ng Tang Fui M; Cheung AS
Andrology; 2020 Nov; 8(6):1519-1529. PubMed ID: 31502758
[TBL] [Abstract][Full Text] [Related]
15. The International Society for Sexual Medicine's Process of Care for the Assessment and Management of Testosterone Deficiency in Adult Men.
Dean JD; McMahon CG; Guay AT; Morgentaler A; Althof SE; Becher EF; Bivalacqua TJ; Burnett AL; Buvat J; El Meliegy A; Hellstrom WJ; Jannini EA; Maggi M; McCullough A; Torres LO; Zitzmann M
J Sex Med; 2015 Aug; 12(8):1660-86. PubMed ID: 26081680
[TBL] [Abstract][Full Text] [Related]
16. Multiple forms of hypogonadism of central, peripheral or combined origin in males with Prader-Willi syndrome.
Radicioni AF; Di Giorgio G; Grugni G; Cuttini M; Losacco V; Anzuini A; Spera S; Marzano C; Lenzi A; Cappa M; Crinò A
Clin Endocrinol (Oxf); 2012 Jan; 76(1):72-7. PubMed ID: 21718342
[TBL] [Abstract][Full Text] [Related]
17. Hormone substitution in male hypogonadism.
Zitzmann M; Nieschlag E
Mol Cell Endocrinol; 2000 Mar; 161(1-2):73-88. PubMed ID: 10773395
[TBL] [Abstract][Full Text] [Related]
18. LH and non-SHBG testosterone and estradiol levels during testosterone replacement of hypogonadal men: further evidence that steroid negative feedback increases as men grow older.
Winters SJ; Wang C;
J Androl; 2010; 31(3):281-7. PubMed ID: 19959827
[TBL] [Abstract][Full Text] [Related]
19. New Biomarkers to Evaluate Hyperandrogenemic Women and Hypogonadal Men.
Karakas SE; Surampudi P
Adv Clin Chem; 2018; 86():71-125. PubMed ID: 30144842
[TBL] [Abstract][Full Text] [Related]
20. Idiopathic hypogonadotropic hypogonadism reversal after testosterone replacement in a 34-year-old male.
Rashid O; Ram N; Farooq S; Kiran Z
BMJ Case Rep; 2017 Jun; 2017():. PubMed ID: 28583920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
